Bothell, Wash.
CMC Biologics is expanding its bioprocessing facility in Bothell, Wash., to house a 3,000-liter bioreactor train. Two 5,000-liter commercial-ready manufacturing lines will also be constructed. The project will support cGMP manufacturing of biopharmaceuticals.